Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Mouth Neoplasms 3 Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Recurrence 2 Mycosis Fungoides 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Laryngeal Neoplasms 2 Vaccinia 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Resectable Non-small Cell Lung Cancer 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Immunoblastic Lymphadenopathy 1

Interventions

Oxaliplatin 9 Leucovorin 8 Fluorouracil 8 Bevacizumab 6 Cetuximab 5 Specimen Handling 4 fludarabine 3 Pemetrexed 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Cyclophosphamide 3 pembrolizumab 2 encorafenib 2 dehydroftorafur 2 aldesleukin 2 Laparoscopy 2 Irinotecan 2 Immunoglobulin G 2 Gemcitabine 2 Folfox protocol 2 Disulfides 2 Conversion to Open Surgery 2 Cisplatin 2 Celecoxib 2 Carboplatin 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 temsirolimus 1 sapanisertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × cemiplimab × 30 days × Clear all

NCT07058012 2026-05-15

EMPIRE

NSABP Foundation Inc

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡